TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vivaderm AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
82
|
96 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
7
|
12 | |
| EBITDA |
14
|
19 | |
| Total assets |
226
|
283 | |
| Current assets |
58
|
110 | |
| Current liabilities |
31
|
94 | |
| Equity capital |
195
|
189 | |
| - share capital |
9
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
86.3%
|
66.8% | |
| Turnover per employee |
41
|
48 | |
| Profit as a percentage of turnover |
8.5%
|
12.5% | |
| Return on assets (ROA) |
3.1%
|
4.2% | |
| Current ratio |
187.1%
|
117.0% | |
| Return on equity (ROE) |
3.6%
|
6.3% | |
| Change turnover |
-14
|
40 | |
| Change turnover % |
2%
|
-15%
|
72% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.